• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞穿透肽中的间隔臂长度会影响壳聚糖/小干扰RNA纳米颗粒用于肺部炎症治疗的递送效果。

The spacer arm length in cell-penetrating peptides influences chitosan/siRNA nanoparticle delivery for pulmonary inflammation treatment.

作者信息

Jeong Eun Ju, Choi Moonhwan, Lee Jangwook, Rhim Taiyoun, Lee Kuen Yong

机构信息

Department of Bioengineering, Hanyang University, Seoul 133-791, Republic of Korea.

出版信息

Nanoscale. 2015 Dec 21;7(47):20095-104. doi: 10.1039/c5nr06903c. Epub 2015 Nov 16.

DOI:10.1039/c5nr06903c
PMID:26568525
Abstract

Although chitosan and its derivatives have been frequently utilized as delivery vehicles for small interfering RNA (siRNA), it is challenging to improve the gene silencing efficiency of chitosan-based nanoparticles. In this study, we hypothesized that controlling the spacer arm length between a cell-penetrating peptide (CPP) and a nanoparticle could be critical to enhancing the cellular uptake as well as the gene silencing efficiency of conventional chitosan/siRNA nanoparticles. A peptide consisting of nine arginine units (R9) was used as a CPP, and the spacer arm length was controlled by varying the number of glycine units between the peptide (R9Gn) and the nanoparticle (n = 0, 4, and 10). Various physicochemical characteristics of R9Gn-chitosan/siRNA nanoparticles were investigated in vitro. Increasing the spacing arm length did not significantly affect the complex formation between R9Gn-chitosan and siRNA. However, R9G10-chitosan was much more effective in delivering genes both in vitro and in vivo compared with non-modified chitosan (without the peptide) and R9-chitosan (without the spacer arm). Chitosan derivatives modified with oligoarginine containing a spacer arm can be considered as potential delivery vehicles for various genes.

摘要

尽管壳聚糖及其衍生物经常被用作小分子干扰RNA(siRNA)的递送载体,但提高基于壳聚糖的纳米颗粒的基因沉默效率仍具有挑战性。在本研究中,我们假设控制细胞穿透肽(CPP)与纳米颗粒之间的间隔臂长度对于提高传统壳聚糖/siRNA纳米颗粒的细胞摄取以及基因沉默效率可能至关重要。由九个精氨酸单元(R9)组成的肽被用作CPP,通过改变肽(R9Gn)与纳米颗粒之间甘氨酸单元的数量来控制间隔臂长度(n = 0、4和10)。在体外研究了R9Gn-壳聚糖/siRNA纳米颗粒的各种物理化学特性。增加间隔臂长度对R9Gn-壳聚糖与siRNA之间的复合物形成没有显著影响。然而,与未修饰的壳聚糖(不含肽)和R9-壳聚糖(无间隔臂)相比,R9G10-壳聚糖在体外和体内递送基因方面都更有效。含有间隔臂的寡聚精氨酸修饰的壳聚糖衍生物可被视为各种基因的潜在递送载体。

相似文献

1
The spacer arm length in cell-penetrating peptides influences chitosan/siRNA nanoparticle delivery for pulmonary inflammation treatment.细胞穿透肽中的间隔臂长度会影响壳聚糖/小干扰RNA纳米颗粒用于肺部炎症治疗的递送效果。
Nanoscale. 2015 Dec 21;7(47):20095-104. doi: 10.1039/c5nr06903c. Epub 2015 Nov 16.
2
Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.九聚精氨酸修饰壳聚糖纳米粒的制备及表征及其用于 siRNA 的递送。
Carbohydr Polym. 2013 Jan 30;92(1):57-62. doi: 10.1016/j.carbpol.2012.08.116. Epub 2012 Sep 8.
3
siRNA-loaded poly(histidine-arginine)-modified chitosan nanoparticle with enhanced cell-penetrating and endosomal escape capacities for suppressing breast tumor metastasis.负载小干扰RNA的聚(组氨酸-精氨酸)修饰壳聚糖纳米颗粒,具有增强的细胞穿透和内体逃逸能力以抑制乳腺肿瘤转移。
Int J Nanomedicine. 2017 Apr 19;12:3221-3234. doi: 10.2147/IJN.S129436. eCollection 2017.
4
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.聚合物性质对壳聚糖/小干扰RNA纳米颗粒制剂及基因沉默的影响。
Biomaterials. 2007 Feb;28(6):1280-8. doi: 10.1016/j.biomaterials.2006.11.004.
5
Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.理性修饰寡聚精氨酸以实现高效 siRNA 递送:siRNA 细胞内转运动力学和结构-活性关系。
Nanomedicine. 2015 Feb;11(2):435-46. doi: 10.1016/j.nano.2014.08.007. Epub 2014 Sep 2.
6
Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.离子交联叶酸-聚(乙二醇)-壳寡糖乳酸纳米粒介导的高效siRNA递送及肿瘤蓄积:用于潜在的靶向卵巢癌基因治疗
Eur J Pharm Sci. 2014 Feb 14;52:48-61. doi: 10.1016/j.ejps.2013.10.011. Epub 2013 Oct 29.
7
PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.聚乙二醇化羧甲基壳聚糖/磷酸钙杂化阴离子纳米粒介导 hTERT siRNA 递用于癌症治疗。
Biomaterials. 2014 Sep;35(27):7978-91. doi: 10.1016/j.biomaterials.2014.05.068. Epub 2014 Jun 14.
8
Oligoarginine-modified chitosan for siRNA delivery.用于小干扰RNA递送的寡聚精氨酸修饰壳聚糖
J Control Release. 2011 Nov 30;152 Suppl 1:e165-6. doi: 10.1016/j.jconrel.2011.08.065.
9
Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.细胞穿透肽偶联脂质纳米粒用于 siRNA 递送。
Biochem Biophys Res Commun. 2014 Feb 21;444(4):599-604. doi: 10.1016/j.bbrc.2014.01.107. Epub 2014 Jan 31.
10
Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: A mechanistic insight.整合素靶向的聚乙二醇化壳聚糖-聚亚乙基亚胺杂化纳米颗粒的细胞内 siRNA 递释动力学:一种机制见解。
J Control Release. 2015 Aug 10;211:1-9. doi: 10.1016/j.jconrel.2015.05.274. Epub 2015 May 16.

引用本文的文献

1
Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives.用于核酸递送的壳聚糖基纳米颗粒:技术层面、应用及未来展望
Pharmaceutics. 2023 Jun 29;15(7):1849. doi: 10.3390/pharmaceutics15071849.
2
Chitosan and Its Structural Modifications for siRNA Delivery.用于小干扰RNA递送的壳聚糖及其结构修饰
Adv Pharm Bull. 2023 Mar;13(2):275-282. doi: 10.34172/apb.2023.030. Epub 2022 Jan 8.
3
Treating Pulmonary Fibrosis with Non-Viral Gene Therapy: From Bench to Bedside.非病毒基因疗法治疗肺纤维化:从实验台到病床边
Pharmaceutics. 2022 Apr 7;14(4):813. doi: 10.3390/pharmaceutics14040813.
4
In Vitro Cellular Uptake and Transfection of Oligoarginine-Conjugated Glycol Chitosan/siRNA Nanoparticles.寡聚精氨酸偶联的壳聚糖/小干扰RNA纳米颗粒的体外细胞摄取与转染
Polymers (Basel). 2021 Dec 1;13(23):4219. doi: 10.3390/polym13234219.
5
Inhaled RNA Therapy: From Promise to Reality.吸入式 RNA 疗法:从承诺到现实。
Trends Pharmacol Sci. 2020 Oct;41(10):715-729. doi: 10.1016/j.tips.2020.08.002. Epub 2020 Sep 4.
6
Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application.细胞穿透肽在人类疾病诊断与治疗中的应用:从临床前研究到临床应用
Front Pharmacol. 2020 May 20;11:697. doi: 10.3389/fphar.2020.00697. eCollection 2020.
7
Efficient Delivery of Triptolide Plus a miR-30-5p Inhibitor Through the Use of Near Infrared Laser Responsive or CADY Modified MSNs for Efficacy in Rheumatoid Arthritis Therapeutics.通过使用近红外激光响应或CADY修饰的介孔二氧化硅纳米颗粒高效递送雷公藤甲素加miR-30-5p抑制剂用于类风湿性关节炎治疗的疗效研究
Front Bioeng Biotechnol. 2020 Mar 17;8:170. doi: 10.3389/fbioe.2020.00170. eCollection 2020.
8
In Vitro Enzymatic Digestibility of Glutaraldehyde-Crosslinked Chitosan Nanoparticles in Lysozyme Solution and Their Applicability in Pulmonary Drug Delivery.在溶菌酶溶液中戊二醛交联壳聚糖纳米颗粒的体外酶消化率及其在肺部药物传递中的应用。
Molecules. 2019 Apr 1;24(7):1271. doi: 10.3390/molecules24071271.
9
Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics.基于纳米颗粒的 CRISPR/Cas9 基因组编辑治疗药物递送系统。
AAPS J. 2018 Oct 10;20(6):108. doi: 10.1208/s12248-018-0267-9.
10
Chitosan promotes immune responses, ameliorating total mature white blood cell numbers, but increases glutamic oxaloacetic transaminase and glutamic pyruvic transaminase, and ameliorates lactate dehydrogenase levels in leukemia mice in vivo.壳聚糖可促进免疫反应,改善白血病小鼠体内的总成熟白细胞数量,但会升高谷草转氨酶和谷丙转氨酶,并改善乳酸脱氢酶水平。
Mol Med Rep. 2017 Sep;16(3):2483-2490. doi: 10.3892/mmr.2017.6923. Epub 2017 Jul 5.